|
|
Volumn 19, Issue 1, 2013, Pages 6-
|
|
No end in sight for telomerase-targeted cancer drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
GV1001 PEPTIDE;
IMETELSTAT;
INDOLE DERIVATIVE;
NICOTINAMIDE;
PEPTIDE FRAGMENT;
TELOMERASE;
CLINICAL TRIAL (TOPIC);
DRUG ANTAGONISM;
ENZYMOLOGY;
HUMAN;
METABOLISM;
MOLECULARLY TARGETED THERAPY;
NEOPLASM;
NOTE;
THROMBOCYTOSIS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS AS TOPIC;
HUMANS;
INDOLES;
MOLECULAR TARGETED THERAPY;
NEOPLASMS;
NIACINAMIDE;
PEPTIDE FRAGMENTS;
TELOMERASE;
THROMBOCYTOSIS;
|
|
EID: 84874571648
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm0113-6 Document Type: Article |
|
Times cited : (40)
|
|
References (0)
|